CAV1 and prostate carcinoma: Consistent with the lipid component of our Cav-1-sphingolipid signature, investigations of advanced cases of castration-resistant prostate cancer identified a distinct plasma lipid signature that includes sphingolipids and glycosphingolipids and that associates with poor prognosis63, further supporting the findings we report here.